Lineage Cell Therapeutics, Inc.

LCTX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2017	114.5M
FY2018	127.1M
FY2019	149.8M
FY2020	153.1M
FY2021	164.5M
FY2022	169.8M
FY2023	172.7M
FY2024	200.2M
FY2025	230.1M
FY2026	249.1M